JSF Financial LLC purchased a new position in Colgate-Palmolive (NYSE:CL – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,730 shares of the company’s stock, valued at approximately $215,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Dimensional Fund Advisors LP increased its holdings in Colgate-Palmolive by 4.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after acquiring an additional 94,837 shares in the last quarter. Covestor Ltd grew its holdings in shares of Colgate-Palmolive by 71.9% during the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock worth $186,000 after buying an additional 1,025 shares in the last quarter. Mackenzie Financial Corp grew its holdings in shares of Colgate-Palmolive by 8.5% during the first quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after buying an additional 146,936 shares in the last quarter. First Western Trust Bank purchased a new stake in shares of Colgate-Palmolive during the first quarter worth $569,000. Finally, Wsfs Capital Management LLC purchased a new stake in shares of Colgate-Palmolive during the first quarter worth $288,000. Hedge funds and other institutional investors own 77.63% of the company’s stock.
Insider Transactions at Colgate-Palmolive
In other news, insider Jennifer Daniels sold 24,703 shares of the stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $79.70, for a total transaction of $1,968,829.10. Following the sale, the insider now owns 52,769 shares of the company’s stock, valued at $4,205,689.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director John P. Bilbrey sold 5,703 shares of the stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $80.81, for a total transaction of $460,859.43. Following the completion of the sale, the director now directly owns 26,257 shares of the company’s stock, valued at $2,121,828.17. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Jennifer Daniels sold 24,703 shares of the stock in a transaction on Friday, May 19th. The stock was sold at an average price of $79.70, for a total value of $1,968,829.10. Following the sale, the insider now directly owns 52,769 shares of the company’s stock, valued at $4,205,689.30. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 187,748 shares of company stock valued at $15,138,660. 0.34% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Trading Up 0.5 %
Colgate-Palmolive (NYSE:CL – Get Rating) last posted its earnings results on Friday, April 28th. The company reported $0.73 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.03. Colgate-Palmolive had a net margin of 8.71% and a return on equity of 348.63%. The company had revenue of $4.77 billion for the quarter, compared to analysts’ expectations of $4.58 billion. During the same quarter in the prior year, the company posted $0.74 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 8.4% compared to the same quarter last year. As a group, research analysts anticipate that Colgate-Palmolive will post 3.14 earnings per share for the current fiscal year.
Colgate-Palmolive Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, May 15th. Stockholders of record on Friday, April 21st were given a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.51%. The ex-dividend date of this dividend was Thursday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.47. Colgate-Palmolive’s dividend payout ratio is currently 100.00%.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on CL. TheStreet lowered shares of Colgate-Palmolive from a “b” rating to a “c+” rating in a report on Friday, January 27th. Evercore ISI upped their target price on shares of Colgate-Palmolive from $85.00 to $91.00 in a report on Monday, May 1st. Royal Bank of Canada upped their target price on shares of Colgate-Palmolive from $82.00 to $83.00 in a report on Monday, May 1st. Barclays lowered their price target on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 31st. Finally, UBS Group boosted their price target on shares of Colgate-Palmolive from $84.00 to $86.00 and gave the company a “buy” rating in a research report on Wednesday, March 29th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $84.75.
Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Get Rating).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.